The forefront of ovarian cancer therapy: update on PARP inhibitors
Mansoor Raza Mirza, Robert L. Coleman, Antonio González-Martı́n, Kathleen N. Moore, Nicoletta Colombo, Isabelle Ray‐Coquard, Sandro Pignata
Topics & Concepts
MedicineVeliparibOlaparibOvarian cancerPARP inhibitorOncologyBevacizumabBiomarkerPopulationInternal medicineClinical trialCancerPoly ADP ribose polymeraseChemotherapyBiochemistryPolymeraseEnvironmental healthChemistryGenePARP inhibition in cancer therapyOvarian cancer diagnosis and treatmentAdvanced Breast Cancer Therapies